BIODESIX (BDSX) stock: insider trades, news & valuation
Net buyingShare price and insider trades
BIODESIX insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $3.1M and 5 sold $118K of BDSX stock on the open market.
Get emailed when insiders cluster-buy stocks like BDSX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BDSX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $1.0M | 3 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $2.1M | 3 | $116K | 15 |
| Q4 2025 | — | 0 | $2K | 5 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 BIODESIX INC insider reported open-market purchases totaling $3.1M, while 5 insiders reported sales totaling $118K. Among insiders with enough purchase history to measure, Jack W Schuler (Emeritus Director) has the highest Insider Score at 38. 0 of 20 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 13SEC | Jack W SchulerEmeritus Director | Buy | 15,000555,810 held (+3%) | $24.47 | $367K | +6.3% | 38 |
| Aug 12SEC | Jack W SchulerEmeritus Director | Buy | 13,900527,110 held (+3%) | $24.25 | $337K | +7.3% | 38 |
| Aug 12SEC | Jack W SchulerEmeritus Director | Buy | 13,700540,810 held (+3%) | $24.01 | $329K | +8.4% | 38 |
| Feb 23SEC | Scott HuttonCEO, President | Sell | 1,49048,767 held (−3%) | $12.78 | $19K | +103.6% | — |
| Feb 23SEC | Gary Anthony PestanoChief Development Officer | Sell | 55610,359 held (−5%) | $12.78 | $7K | +103.6% | — |
| Feb 23SEC | Robin Harper CowieCFO | Sell | 53516,231 held (−3%) | $12.78 | $7K | +103.6% | — |
| Feb 23SEC | Kieran O'kaneChief Commercial Officer | Sell | 5359,819 held (−5%) | $12.78 | $7K | +103.6% | — |
| Feb 23SEC | Chris VazquezChief Accounting Officer | Sell | 2111,586 held (−12%) | $12.78 | $3K | +103.6% | — |
| Feb 11SEC | Scott HuttonCEO, President | Sell | 3,55945,413 held (−7%) | $10.08 | $36K | +158.1% | — |
| Feb 11SEC | Robin Harper CowieCFO | Sell | 94115,297 held (−6%) | $10.08 | $9K | +158.1% | — |
| Feb 11SEC | Kieran O'kaneChief Commercial Officer | Sell | 5848,885 held (−6%) | $10.08 | $6K | +158.1% | — |
| Feb 11SEC | Gary Anthony PestanoChief Development Officer | Sell | 5409,387 held (−5%) | $10.08 | $5K | +158.1% | — |
| Feb 11SEC | Chris VazquezChief Accounting Officer | Sell | 1011,234 held (−8%) | $10.08 | $1K | +158.1% | — |
| Jan 27SEC | Jack W SchulerEmeritus Director | Buy | 80,0001,543,210 held (+5%) | $11.81 | $945K | +120.3% | 38 |
| Jan 27SEC | Jack W SchulerEmeritus Director | Buy | 20,0001,563,210 held (+1%) | $11.80 | $236K | +120.5% | 38 |
| Jan 26SEC | Jack W SchulerEmeritus Director | Buy | 82,4651,463,210 held (+6%) | $10.96 | $904K | +137.4% | 38 |
| Jan 20SEC | Scott HuttonCEO, President | Sell | 97038,974 held (−2%) | $8.15 | $8K | +219.3% | — |
| Jan 20SEC | Robin Harper CowieCFO | Sell | 29813,654 held (−2%) | $8.15 | $2K | +219.3% | — |
| Jan 20SEC | Kieran O'kaneChief Commercial Officer | Sell | 2987,869 held (−4%) | $8.15 | $2K | +219.3% | — |
| Jan 20SEC | Gary Anthony PestanoChief Development Officer | Sell | 2988,446 held (−3%) | $8.15 | $2K | +219.3% | — |
| Jan 20SEC | Chris VazquezChief Accounting Officer | Sell | 831,072 held (−7%) | $8.15 | $676 | +219.3% | — |
| Nov 13SEC | Scott HuttonCEO, President | Sell | 18937,311 held (−1%) | $7.62 | $1K | +241.5% | — |
| Nov 13SEC | Robin Harper CowieCFO | Sell | 5013,147 held (−0%) | $7.62 | $381 | +241.5% | — |
| Nov 13SEC | Kieran O'kaneChief Commercial Officer | Sell | 257,362 held (−0%) | $7.62 | $190 | +241.5% | — |
| Nov 13SEC | Gary Anthony PestanoChief Development Officer | Sell | 237,939 held (−0%) | $7.62 | $175 | +241.5% | — |
| Nov 13SEC | Chris VazquezChief Accounting Officer | Sell | 13936 held (−1%) | $7.62 | $99 | +241.5% | — |
Insiders at BIODESIX INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Jack W SchulerEmeritus Director | $3.1M | — | Aug 13, 2026 | 38 |
| Scott HuttonCEO, President | — | $64K | Feb 23, 2026 | — |
| Robin Harper CowieCFO | — | $19K | Feb 23, 2026 | — |
| Kieran O'kaneChief Commercial Officer | — | $15K | Feb 23, 2026 | — |
| Gary Anthony PestanoChief Development Officer | — | $15K | Feb 23, 2026 | — |
| Chris VazquezChief Accounting Officer | — | $4K | Feb 23, 2026 | — |
BDSX stock: common questions
Are BIODESIX INC insiders buying BDSX stock?
In the past 12 months, 1 insiders reported open-market purchases of BDSX worth $3.1M. The latest was Emeritus Director Jack W Schuler bought $367K of BDSX at $24.47.
Are BIODESIX INC insiders selling BDSX stock?
5 insiders reported sales worth $118K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BDSX's 52-week range?
Over the past year BDSX has traded between $5.46 and $30.60. It last closed at $26.02 on Oct 9, 2026.